Cellect Biotechnology Stock Forecast, Price & News

Cellect Biotechnology (NASDAQ:APOP) Frequently Asked Questions

What stocks does MarketBeat like better than Cellect Biotechnology?

Wall Street analysts have given Cellect Biotechnology a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cellect Biotechnology wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cellect Biotechnology?

Cellect Biotechnology saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 72,000 shares, a drop of 52.8% from the August 31st total of 152,700 shares. Based on an average daily trading volume, of 471,900 shares, the days-to-cover ratio is presently 0.2 days.
View Cellect Biotechnology's Short Interest.

When is Cellect Biotechnology's next earnings date?

Cellect Biotechnology is scheduled to release its next quarterly earnings announcement on Friday, November 19th 2021.
View our earnings forecast for Cellect Biotechnology.

How were Cellect Biotechnology's earnings last quarter?

Cellect Biotechnology Ltd. (NASDAQ:APOP) released its earnings results on Tuesday, August, 24th. The company reported ($0.86) earnings per share (EPS) for the quarter.
View Cellect Biotechnology's earnings history.

How has Cellect Biotechnology's stock been impacted by Coronavirus (COVID-19)?

Cellect Biotechnology's stock was trading at $3.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APOP shares have increased by 286.0% and is now trading at $13.20.
View which stocks have been most impacted by COVID-19.

When did Cellect Biotechnology's stock split? How did Cellect Biotechnology's stock split work?

Cellect Biotechnology's stock split before market open on Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were issued to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of Cellect Biotechnology stock prior to the split would have 200 shares after the split.

Who are Cellect Biotechnology's key executives?

Cellect Biotechnology's management team includes the following people:

• Shai Yarkoni, Chief Executive Officer & Director
• Amos Ofer, Chief Operating Officer
• Yaron Ben-Oz, Chief Financial Officer

Who are some of Cellect Biotechnology's key competitors?

Some companies that are related to Cellect Biotechnology include NeuroMetrix (NURO), ReShape Lifesciences (RSLS), Daxor (DXR), Universal Media Group (UMGP), Sigyn Therapeutics (SIGY), INVO Bioscience (INVO), Vivos (RDGL), Motus GI (MOTS), NeuroOne Medical Technologies (NMTC), InspireMD (NSPR), Biostage (BSTG), Sintx Technologies (SINT), Oncologix Tech (OCLG), Plus Therapeutics (PSTV) and Arch Therapeutics (ARTH).
View all of APOP's competitors.

What other stocks do shareholders of Cellect Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL).

What is Cellect Biotechnology's stock symbol?

Cellect Biotechnology trades on the NASDAQ under the ticker symbol "APOP."

How do I buy shares of Cellect Biotechnology?

Shares of APOP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cellect Biotechnology's stock price today?

One share of APOP stock can currently be purchased for approximately $13.20.

How much money does Cellect Biotechnology make?

Cellect Biotechnology has a market capitalization of $12.90 million.

How many employees does Cellect Biotechnology have?

Cellect Biotechnology employs 2,020 workers across the globe.

What is Cellect Biotechnology's official website?

The official website for Cellect Biotechnology is www.cellect.co.

Where are Cellect Biotechnology's headquarters?

Cellect Biotechnology is headquartered at 23 HATA`AS STREET, KFAR SABA L3, 44425.

How can I contact Cellect Biotechnology?

Cellect Biotechnology's mailing address is 23 HATA`AS STREET, KFAR SABA L3, 44425. The company can be reached via phone at (729) 974-1444 or via email at [email protected].